Bryan Supran
CIK: 0001511797
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)1 (33.3%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (66.7%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ALNY
ALNYLAM PHARMACEUTICALS, INC.
Officer
Discretionary Trading P&L
Holdings
About SUPRAN BRYAN
SUPRAN BRYAN (SEC CIK 0001511797) files insider reports with the SEC as EVP, CLO and Secretary of ALNYLAM PHARMACEUTICALS, INC. (ALNY).
Signal8 holds 4 ownership filings by SUPRAN BRYAN (1 Form 3, 3 Form 4), filed between Sep 22, 2025 and Oct 6, 2026. Those filings report 3 transactions, from Oct 1, 2025 to Oct 2, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on SUPRAN BRYAN's filings is in CAMBRIDGE, MA.
Recent filings by SUPRAN BRYAN
Other insiders filing for ALNYLAM PHARMACEUTICALS, INC. (ALNY)
- Greenstreet Yvonne, Chief Executive Officer
- PYOTT DAVID E I, Director
- Cravatt Benjamin, Director
- Sigal Charles Elliott, Director
- SCHULMAN AMY W, Director
- Reitan Colleen F, Director